Grapheal is a Medtech spinoff of CNRS-Grenoble, France, producing connected biosensors coupled to mobile technologies. Grapheal brings connectivity to biosensing by designing embedded biosensors and wearables. Grapheal’s devices aim to provide field diagnostics and remote patient monitoring solutions, focusing on pathogens detection and wound care. Grapheal has finalized the design of two products and has been named a CES® 2022 « Best in Innovation » Awards Honoree for its digital diagnostic test TestNpass™.

Funding : Looking for Serie A – Grapheal is raising $7 million for supporting its industrial deployment and accelerating its go-to-market